Supporting holistic care for patients with tuberculosis in a remote Indigenous community: a case report by Miller, Andrea et al.
CLINICAL CASE REPORT
AUTHORS
Andrea Miller  FRACGP, FARGP (Adv Skill Adult Internal Medicine), Senior Medical Officer
Alice Cairns  PhD, HOT North Research Fellow *
Annah Richardson  Master of Nursing (Rural and Remote), Clinical Nurse
Jill Lawrence  Aboriginal and Torres Strait Islander Indigenous Health Worker
CORRESPONDENCE
*Dr Alice Cairns alice.cairns@jcu.edu.au
AFFILIATIONS
 Weipa Integrated Health Services, PO Box 341, Weipa, Queensland 4874, Australia
 Centre for Rural and Remote Health, James Cook University, Weipa Hospital PO Box 341, Weipa, Queensland 4874, Australia
 Weipa Integrated Health Service, Lot 497 John Evans Drive, Weipa, Queensland 4874, Australia
 Napranum Primary Health Care Clinic, Munding Road, Napranum, Queensland 4874, Australia
PUBLISHED
26 February 2020 Volume 20 Issue 1
HISTORY
RECEIVED: 11 July 2019
REVISED: 28 December 2019
ACCEPTED: 28 January 2020
CITATION
Miller A, Cairns A, Richardson A, Lawrence J.  Supporting holistic care for patients with tuberculosis in a remote Indigenous community: a
case report. Rural and Remote Health 2020; 20: 5552. https://doi.org/10.22605/RRH5552
This work is licensed under a Creative Commons Attribution 4.0 International Licence
ABSTRACT:
Context:  Tuberculosis (TB) is a serious infectious disease with high
rates of morbidity and mortality if left untreated. In Australia, TB
has been virtually eradicated in non-Indigenous Australian-born
populations but in remote Aboriginal and/or Torres Strait Islander
communities TB presents a rare but significant public health issue.
Remote health services are most likely to encounter patients with
suspected and confirmed TB diagnosis but may be unprepared for
supporting someone with this disease and the complexities of
balancing public health risk with patient autonomy.
Issue:  This case study will outline the process for diagnosis and
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treatment of a TB patient in a remote Cape York community. This
case involved significant delay in diagnosis and required several
strategies to achieve successful disease eradication. The process of
treatment, however, had a significant effect on the patient’s
physical health, and social and emotional wellbeing.
Lessons learned:  This case highlights the importance of early
collaboration between medical, nursing, Indigenous health worker
and allied health services and the importance of technology such
as electronic information records to support opportunistic access
to diagnostic services and treatment. The enactment of the TB
protocol should include discussions about the consequences of
any restrictions of movement, employment or social/community
roles. Identifying alternative opportunities to engage in meaningful
roles may reduce the impact the disease has on a patient’s quality
of life.
Keywords:




Mycobacterium tuberculosis is one of the most ancient bacteria to
infect humans, and those without treatment of active infection
have a 5-year survival of less than 50% . Tuberculosis (TB) remains
one of the primary causes of mortality in developing countries . TB
diagnosis and treatment are unfamiliar to most urban Australian
health practitioners; this disease, virtually eradicated from the
Australian medical lexicon by the 1980s . Of contemporary cases in
Australia, 90% occur in those born overseas (migrants) . The
remaining 10% of cases occur predominantly in Indigenous
populations, at a rate six times that of non-Indigenous
Australians . Indigenous people living in Cape York and on the
Torres Strait Islands have historically higher rates of TB than people
in other parts of Australia . Proximity to Papua New Guinea, which
has a TB prevalence among one of the highest in the world, and
the social and biological factors increasing risk of transmission,
continues to put these communities at risk of this communicable
disease .
Public health guidelines recommend anti-TB treatment commence
within 3 days of diagnosis of active disease to mitigate the risk of
transmission, with medication delivered as directly observed
therapy in daily or three times weekly dosing . The treatment
cure rate for Indigenous people in Australia in recent years has
been approximately 10% less than for non-Indigenous groups .
One primary contributor to treatment failure is non-adherence to
medication, increasing the potential for the evolution of multi-
drug resistant TB, an increasingly global concern. A study
published in 2015 reported 13% of cultured TB in Australia was
drug resistant to first line anti-TB agents . Challenges to
medication adherence are multifactorial and include structural
factors such as organisation of treatment and care for patients;
and individual/patient factors such as patient interpretations of
illness and wellness, knowledge, attitudes and beliefs about
treatment, personal characteristics and adherence behaviour,
influence of side effects on treatment adherence, and family,
community and household influences .
There are considerable challenges for health professionals who
treat patients with TB, as they attempt to balance public health
concerns and the maintenance of patient autonomy and quality of
life. The remote environment and the cultural complexities of
providing health care to Indigenous Australians compound these
challenges. Indigenous people demonstrate lower TB cure rates
than other populations, with increased vulnerability of remote
Indigenous communities to disease outbreaks. There is a
considerable body of literature exploring these issues in
developing countries but little documentation of these
complexities in the Australian remote Indigenous context.
This case report will explore the challenges of diagnosis and
coordination of treatment of TB in a very remote Indigenous
community and the impact this process had on the physical, social
and emotional wellbeing of an individual. The patient has provided
written consent for the publication of this case report.
Issue
The index case is a middle-aged Aboriginal woman residing in a
remote Cape York Indigenous community. She initially presented
to the local primary healthcare centre (PHCC) with cough and
fever, at which time a local outpatient chest radiograph
demonstrated a novel apical lung lesion. Multiple serial
radiographs were obtained over a few months, with non-resolution
of the lesion, with a CT radiograph recommended for definitive
diagnosis, a service that requires transfer to the closest tertiary
hospital, more than 800 km away. The patient did not attend for
this scan and was lost to follow-up. The patient re-presented to
the PHCC 3 years later and a CT chest radiograph, with findings
suggestive of TB, was completed. Sputum sample smears
confirmed Mycobacterium tuberculosis 3 months post-CT. Although
at this stage she was asymptomatic, these results confirmed what
appeared to be an autochthonous case of active pulmonary TB
from an unknown source.
As per guidelines and under the remote supervision of the state-
led TB control unit, the patient was admitted to the local remote
hospital to commence the first 2 weeks of drug treatment.
Attempts at isolating her in hospital for induction treatment
proved unsuccessful as the patient self-discharged. The patient
continued to engage with the health staff in the community
although her adherence to medical treatment and appointments
was inconsistent. To reduce the public health risk, the TB unit
advised the patient to cease her welfare/government supported
employment at the local childcare centre. The loss of her work role
appeared to precipitate an increase in alcohol and cannabis use,












complicated the medical management of this patient, with the
health service eventually using a modified directly observed
therapy (DOT) approach to optimise medication adherence.
Treatment strategies
Following the initial failed hospital admission, DOT was trialled in
the community. Initially, a clinical nurse consultant, with support
from an Indigenous Health Worker (IHW), delivered medication
Monday to Friday with weekend medication left with the patient
on a Friday. This resulted in suboptimal adherence as locating the
patient was problematic. The period directly after diagnosis and
subsequent withdrawal from work was the most chaotic for the
patient. The patient’s loss of a consistent daily structure that would
ordinarily support treatment adherence significantly affected the
delivery of treatment in the first few months.
Alternative treatment regimens were trialled, including three times
weekly treatment and provision of take-home medications for
weekends; however, there remained uncertainty with adherence
when self-administering. Finally, in consultation with the patient,
the use of a pre-packed medication system (Webster-pak) was
employed. Initially the registered nurse and an IHW observed self-
administration of medications from the Webster-pak daily. As the
use of the Webster-pak did not require a registered nurse to
administer medication, the case management of the patient care
was able to be transferred to the IHW, who was able to build a
relationship with the patient to facilitate more reliable treatment
adherence. Visits were short (approximately 5 min) but daily.
Through building a medication routine acceptable to the patient,
the IHW could gradually reduce the level of support provided to
the patient to ensure medication adherence. This short-term
intensive support to develop a medication routine had positive
unintended consequences such as improving the consistency of
the patient’s daily routine, reducing alcohol and improving her
nutritional intake. The patient also re-engaged with her
employment provider. She ceased medication after 14 months of
therapy and thus far is considered cured of TB, for ongoing
surveillance.
Lessons learned
This case report describes the diagnosis of TB in an Aboriginal
person residing in a remote community in Cape York and the
treatment strategies that resulted in successful disease eradication.
Although the desired outcome of cure was achieved, limited access
to timely and appropriate health services and the lack of
engagement with the patient outside of their immediate medical
needs resulted in delayed diagnosis, extended treatment
requirements and significant disruption to the patient’s work and
social roles.
Two interrelated categories can be used as a framework for
exploring the challenges faced by the patient and health service in
treating this case: the health service and environmental factors;
and individual, personal and lifestyle factors.
Health service and environmental factors
Several health service factors were identified through this case
study as impacting on the provision of best practice for the
patient. These included staff unfamiliar with diagnosis and
treatment of TB, poor access to diagnostic tools such as CT scan,
paper-based records restricting timely communication between
local hospital and primary health care staff, and a lack of
multidisciplinary involvement to reduce the burden of the disease
on the patient’s social and occupational roles.
Both patient delay in seeking health care and health systems delay
contribute to delayed diagnosis and treatment, potentially
increasing morbidity and public health risk , as in this case.
Previous research has reported Indigenous Australians have been
less likely to experience a delay in diagnosis than other groups .
When this patient initially presented with cough and fever, and
radiographical evidence of an apical lung lesion, the index of
suspicion for TB should have been higher, with unfamiliarity and
the relative rarity of this illness in Cape York possibly contributing
to this delayed diagnosis. Access to CT imaging for all residents in
Torres Strait and Cape York involve air travel to Cairns and at least
one overnight stay. This can be a significant burden for patients
who are responsible for caring for others (children, elders) or have
other family or community responsibilities, and navigating the
complexities of tertiary level services and location has previously
been demonstrated to present a barrier to accessing services for
remote Indigenous residents . Initiation of treatment was also
compromised by distance, as medications took time to arrive from
Cairns and did not arrive prior to the patient’s self-discharge,
resulting in further delays to continuation of treatment and an
associated increase in public health risk. 
In Australia, following the diagnosis of active TB, treatment is
recommended to commence within 72 hours , with a 2-week
hospitalisation recommended at the initiation of treatment. These
protocols exist out of context to this patient’s remote community
setting and hospital service and in this case the execution of the TB
protocol was not well considered from an organisational
perspective. Due to unfamiliarity, health service staff experienced
reduced comfort levels with respect to managing this patient. This
resulted in staff focusing on the biomedical and risk management
of this infectious disease without considering how to best support
someone, who felt relatively well, to stay in hospital for 2 weeks.
Two attempts at hospitalisation resulted in self-discharge despite
the patient’s willingness to treat the TB and agreeing to the
admissions. In hindsight, this was unsurprising as there was no
discussion with the patient or health staff about how the patient
would spend their time in hospital. There was no referral to social
work for input and at the time the health service did not have an
occupational therapy service that could support this patient to
maintain occupational roles during the treatment process.
The combination of DOT and a case management model better
served the needs of this patient and ensured her care was
maintained within the complicated context of this remote health
service. Strategies used by the case manager involved raising
issues regarding patient engagement at the daily primary care staff
meetings and weekly multidisciplinary team meetings. The success





when used in conjunction with DOT, has been reported within the
literature  and this model certainly reduced fragmentation of
communication in this case (a problem accentuated by separate
paper-based records between the hospital and PHCC). A lack of
shared electronic medical records and electronic patient recall
system meant that there was a heavy reliance on verbal and email
communications, which were not always filed in a timely manner or
sent to all relevant parties involved in patient care. This not only
resulted in disjointed provision of service and missed opportunities
for patient review, but also occasionally put staff at risk who were
not aware that this patient, who presented sporadically to the
emergency department, required airborne precautions for TB. It
has been suggested that a common electronic platform of
communication can improve management of TB, especially with
respect to the complicated drug regimens in multi-drug resistant
TB , and this certainly would have been helpful in this case.
Individual, personal and lifestyle factors
Individual and cultural factors affect the adherence to treatment in
TB . In this case, the patient was agreeable to treatment, attended
medical appointments and was open to discussions about her
illness and the treatment regimen. Regardless of this cooperation,
it became quickly obvious that competing needs of cultural and
personal priorities and the adherence to the intensity of the
treatment were going to place the patient at risk of treatment
failure and development of multi-drug resistant TB. The health
priorities for many patients with chronic conditions are not that of
disease control and eradication but the maintenance of daily social
activities . Stigma from the community can limit willingness to
engage in treatment , and a ‘shame’ factor was identified in this
case as a significant barrier to daily DOT, with the patient
embarrassed by being singled out by the health service in front of
her family. As observed in this case with the transition of case
management to the Indigenous health worker, the provision of a
culturally competent health service in-conjunction with medication
adherence strategies (Webster-pak, simplified dosing), can
improve treatment outcomes in Indigenous patients .
Due to the perceived public health risk in this case, the patient was
advised to withdraw from her role as a childcare worker, resulting
in disrupted interaction with others and a degree of social
isolation, with no redress for this offered by the health service. In
patients with TB, as with many diseases, unemployment and low
socioeconomic status are associated with a lower baseline health-
related quality of life, and the psychosocial burden can sometimes
be greater than the physical burden . The advice to cease
employment was provided without the support of a social worker
or occupational therapist. If the public health risk requires patients
to restrict work or other social roles, efforts should be made to
ensure this is implemented in consultation with relevant
stakeholders and to enlist support of a multidisciplinary team to
mitigate the financial and psychosocial losses to the patient. In
some cases, it may be possible to negotiate alternative
employment or social roles, which may have been helpful in this
case. 
Conclusion
This case illustrated the challenges of diagnosis and management
of TB in a remote Indigenous community in Far North Queensland,
including delays in diagnosis related to the remote environment,
multiple paper-based record systems, and a focus on biomedical
needs and individual patient factors. In very remote northern
Australia, a model to support timely diagnosis with an increased
threshold for suspicion of TB would be appropriate. Diagnostic
support, ideally with local access to CT services, is equally as
important as an effective treatment model with respect to
reducing public health risk and patient morbidity. A single
electronic medical record could have effectively mitigated the risk
of communication errors and would have facilitated a more
coordinated response between hospital and primary care services.
Due to the prolonged nature of treatment of TB and requirement
for strict adherence to the drug regimen, consideration of the
impact of this treatment on quality of life is essential for patient
collaboration. The effects of the potential restriction of
employment and competing social priorities need to be pre-
empted and addressed in order to optimise treatment adherence.
Early involvement of Indigenous health workers and the
identification of a case manager is recommended to support
individualised and culturally specific, patient-centred care.
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